Research Categories
- Anesthesia
- Arthroscopy
- Biologics/Biomaterials
- Cancer Devices
- Cardiovascular
- Cosmetic Devices
- Dental
- Diabetes
- Diagnostics
- Dialysis
- Drug Delivery
- Ear, Nose, Throat
- Endoscopy
- Gastrointestinal (GI)
- General Surgery
- Gynecology Devices
- Healthcare IT
- Hearing Devices
- Imaging
- Immunology
- Infusion Therapy
- Laparoscopy
- Minimally Invasive Surgery
- Neurology Devices
- Oncology
- Operating Room Equipment
- Ophthalmics Devices
- Orthopedics
- Patient Monitoring
- Peripheral Vascular
- Respiratory Devices
- Robotics & Navigation
- Sleep Apnea & Diagnostics
- Spine
- Stents
- Telehealth & Telemedicine
- Tissue Repair
- Urology
- Vascular Access
- Video Hi-Tech
- Women's Health
- Wound Care
Biologics & Biomaterials
The orthopedic biomaterials market includes bone graft substitutes, growth factors, orthopedic stem cells, cell therapy, hyaluronic acid viscosupplementation, cartilage repair and machined bone allografts. The orthopedic biomaterials market consists of materials that are organic, inorganic or synthetic in nature. These materials are implanted or applied in or near the indicated bone to facilitate healing, encourage bone tissue augmentation, compensate in areas where bone tissue is depleted and restore structure to allow for repair.
Showing 1–12 of 17 results
Orthopedic Biomaterials Market Size, Share and Trend Analysis | Global | 2025-2031 | MedSuite | Includes: Bone Graft Substitutes Market, Orthopedic Growth Factors Market, and 3 more
Overall, the global orthopedic biomaterials device market was valued at $7.3 billion in 2024. This is expected to increase over the forecast period at a CAGR of 4.0% to reach $9.6 billion. The full report suite on the global market for orthopedic biomaterials devices includes the bone graft substitute market, represented by the allograft, demineralized […]
more...Orthopedic Growth Factor Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Cervical Disc Degeneration Market, Tibial Fracture Market, and 2 more
The global orthopedic growth factor market was valued at $1.05 billion in 2024. This is expected to increase over the forecast period at a CAGR of 2.2% to reach $1.2 billion. The full report suite on the global orthopedic growth factor market categorizes growth factors into four indication types: cervical disc degeneration, tibial fractures, spine […]
more...Orthopedic Bone Graft Substitute Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Allograft Market, Demineralized Bone Matrix Market, and 1 more
The global bone graft substitute market was valued at approximately $2.83 billion in 2024. This is expected to increase over the forecast period at a CAGR of 4.1% to reach approximately $3.75 billion. The full report suite on the global market for bone graft substitute (BGS) includes allograft BGS, demineralized bone matrix (DBM) allograft BGS […]
more...Hyaluronic Acid Viscosupplementation Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Single Injection Market, Two Injection Market, and 2 more
The global hyaluronic acid viscosupplementation market was valued at $2.5 billion in 2024. This is expected to increase over the forecast period at a CAGR of 2.9% to reach $3 billion. The full report suite on the global market for hyaluronic acid (HA) viscosupplementation includes single injection, two injections, three injections and five injections. This […]
more...Orthopedic Cartilage Repair Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Osteochondral Allograft Market, Meniscal Allograft Market, and 2 more
The global orthopedic cartilage repair market was valued at $405 million in 2024. This is expected to increase over the forecast period at a CAGR of 9.2% to reach $750 million. The full report suite on the global market for orthopedic cartilage repair includes osteochondral allografts, meniscal allografts, autologous chondrocytes and osteochondral autograft. This report […]
more...Orthopedic Biomaterials Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: Bone Graft Substitutes, Orthopedic Growth Factors, Cellular Allografts, and 3 more
The full report suite on the U.S. market for orthopedic biomaterials includes bone graft substitutes, which are represented by allografts, demineralized bone matrices (DBMs), xenografts and synthetic bone graft markets. The report also includes orthopedic growth factors; cellular allografts; orthopedic cell therapy, represented by bone marrow aspirate concentrate and platelet-rich plasma; hyaluronic acid (HA) viscosupplementation in single-, two-, three- and five-injection cycles; and, finally, orthopedic cartilage repair. Cartilage repair is represented by the osteochondral allograft, meniscal allograft, autologous chondrocyte implantation, particulated juvenile allograft and microfracture adjunct segments.
more...Orthopedic Cell Therapy Market Size, Share, and Trend Analysis | Global | 2025-2031 | MedCore | Includes: Platlet-Rich Plasma Market and Bone Marrow Aspirate Concentrate Market
The global orthopedic cell therapy market was valued at $551.3 million in 2024. This is expected to increase over the forecast period at a CAGR of 7.2% to reach $895.8 million. The full report suite on the global market for orthopedic cell therapy includes platelet-rich cell therapy and bone marrow cell therapy. This report includes […]
more...Orthobiologics Market Analysis, Size, Trends | China | 2020-2026 | MedSuite
In 2020, the Chinese orthobiologics market size was valued at $460.7 million, with over 424,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 6% to reach $690.8 million in 2026. Throughout this medical market research, we analyzed 28 orthobiologics companies across China […]
more...Orthobiologics Market Analysis, Size, Trends | Japan | 2020-2026 | MedSuite
In 2020, the Japanese orthobiologics market size was valued at $426.9 million, with over 221,000 bone grafting procedures performed every year. The market size is expected to fluctuate over the forecast period with a -0.4% compound annual growth rate (CAGR). Throughout this medical market research, we analyzed 16 orthobiologics companies across Japan and used our […]
more...Orthobiologics Market Analysis, Size, Trends | India | 2020-2026 | MedSuite
In 2020, the Indian orthobiologics market size was valued at $76.2 million, with over 520,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 12.4% to reach $172.3 million in 2026. Throughout this medical market research, we analyzed 23 orthobiologics companies across India […]
more...Orthobiologics Market Analysis, Size, Trends | South Korea | 2020-2026 | MedSuite
In 2020, the South Korean orthobiologics market size was valued at $141.6 million, with over 200,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $181.5 million in 2026. Throughout this medical market research, we analyzed 16 orthobiologics companies across […]
more...